Important updates regarding NHF's 72nd Bleeding Disorders Conference.
These continuing education activities are intended for hematologists, pediatricians, and other healthcare professionals who manage patients with hemophilia.
BioMarin is working with health authorities and governmental regulatory agencies globally, to ensure the safety of all those involved in their clinical trial program, including enrolled participants, investigators, and staff.
Many of us are looking for new ways to stay active during the COVID-19 pandemic, but it’s important to find an activity that works for you and your bleeding disorder.
The National Hemophilia Foundation will be holding our quarterly Board of Directors meeting on Thursday, May 28th at 7:00 PM EDT.
Information and techniques you and your family can use to stay healthy during the COVID-19 pandemic.
Researchers for this observational study focused on macroscopic hematuria, hemophilia, and potential links to family history of hypertension.
The executive summary of the NHF/HFA Safety Summit is available for public commentary.
eNewsletter Sign Up
Steps for Living
Victory for Women
Unite for Bleeding Disorders Walk
Donate Your Car